Recent News

• 09.04.2025 - Sol-Gel Announces Health Canada Approval of EPSOLAY®
• 09.04.2025 - Sol-Gel Announces Health Canada Approval of EPSOLAY®
• 08.15.2025 - Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
• 08.15.2025 - Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
• 05.23.2025 - Sol-Gel Reports First Quarter 2025 Results
• 05.23.2025 - Sol-Gel Reports First Quarter 2025 Results

Recent Filings

• 09.04.2025 - EX-99.1 EX-99.1
• 09.04.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 08.29.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.18.2025 - EFFECT Notice of Effectiveness
• 08.15.2025 - POS AM Post-Effective amendments for registration statement
• 08.15.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 08.15.2025 - EX-99.1 EX-99.1
• 06.12.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 05.23.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 05.23.2025 - EX-99.1 EX-99.1